Physician profile

Jenna M Hebert

Advanced Practice Midwife · Midland, MI

NPI 1386380251

$327.11

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$188.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Hologic Sales and Service, LLC $116.67 2022-2023 Coolseal Generator
Abbvie INC. $42.41 2024
Astellas Pharma US INC $37.46 2023-2024 Veozah
Biogen, INC. $26.08 2023
Organon LLC $19.45 2023 Nexplanon
Axonics, INC. $18.89 2022
Acessa Health INC. $17.44 2022
Exact Sciences Corporation $16.90 2023 Cologuard Collection Kit
Pfizer INC. $16.44 2024
Coopersurgical, INC. $15.37 2023 Paragard T 380a

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jenna M Hebert

$327.11

in general payments reported 2019-2025

Years
2022-2024
Top company
Hologic Sales and Service, LLC

https://glasscript.com/doctor/11359713/jenna-m-hebert

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.